Show simple item record

dc.contributor.authorBebek, Nerses
dc.contributor.authorŞirin, Nermin Görkem
dc.contributor.authorBaykan, Betül
dc.contributor.authorAtalar, Arife Çimen
dc.date.accessioned2021-12-10T12:03:03Z
dc.date.available2021-12-10T12:03:03Z
dc.identifier.citationAtalar A. Ç. , Şirin N. G. , Bebek N., Baykan B., "Predictors of successful valproate withdrawal in women with epilepsy.", Epilepsy & behavior : E&B, cilt.119, ss.107980, 2021
dc.identifier.issn1525-5050
dc.identifier.othervv_1032021
dc.identifier.otherav_a5078a88-e7c4-444b-b4c7-6118d4ffbc56
dc.identifier.urihttp://hdl.handle.net/20.500.12627/173144
dc.identifier.urihttps://doi.org/10.1016/j.yebeh.2021.107980
dc.description.abstractObjective: Valproate (VPA) use was restricted due to its teratogenic risks in women with epilepsy (WWE). We aimed to assess the outcome and predictors of treatment decisions of withdrawal/switch or continuation of VPA in WWE. Methods: We included 214 consecutive WWE with a follow-up time of 9.57 +/- 7.04 years, who have used (n = 142) or are still using VPA (n = 72) during their reproductive ages. The demographic, clinical, and electroencephalography (EEG) properties of WWE who could withdraw (successful withdrawal; n = 142) and could not withdraw VPA (unsuccessful withdrawal; n = 36) were compared statistically.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectKLİNİK NEUROLOJİ
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSinirbilim ve Davranış
dc.subjectDAVRANIŞ BİLİMLERİ
dc.titlePredictors of successful valproate withdrawal in women with epilepsy.
dc.typeMakale
dc.relation.journalEpilepsy & behavior : E&B
dc.contributor.department, ,
dc.identifier.volume119
dc.identifier.startpage107980
dc.identifier.endpage107980
dc.contributor.firstauthorID2622843


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record